Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial.

Koutkia P, Canavan B, Breu J, Torriani M, Kissko J, Grinspoon S.

JAMA. 2004 Jul 14;292(2):210-8.

PMID:
15249570
2.

Growth hormone axis treatments for HIV-associated lipodystrophy: a systematic review of placebo-controlled trials.

Sivakumar T, Mechanic O, Fehmie DA, Paul B.

HIV Med. 2011 Sep;12(8):453-62. doi: 10.1111/j.1468-1293.2010.00906.x. Epub 2011 Jan 25. Review.

3.

Use of recombinant human growth hormone in HIV-associated lipodystrophy.

Burgess E, Wanke C.

Curr Opin Infect Dis. 2005 Feb;18(1):17-24. Review.

PMID:
15647695
4.

Growth hormone deficiency and human immunodeficiency virus.

Rochira V, Guaraldi G.

Best Pract Res Clin Endocrinol Metab. 2017 Feb;31(1):91-111. doi: 10.1016/j.beem.2017.02.006. Epub 2017 Feb 24. Review.

PMID:
28477736
5.

Pathophysiology of GHRH-growth hormone-IGF1 axis in HIV/AIDS.

Jain S, Desai N, Bhangoo A.

Rev Endocr Metab Disord. 2013 Jun;14(2):113-8. doi: 10.1007/s11154-013-9245-9. Review.

PMID:
23657561
6.

Pathogenesis and treatment of HIV lipohypertrophy.

Leung VL, Glesby MJ.

Curr Opin Infect Dis. 2011 Feb;24(1):43-9. doi: 10.1097/QCO.0b013e3283420eef. Review.

7.

Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy.

Dhillon S.

Drugs. 2011 May 28;71(8):1071-91. doi: 10.2165/11202240-000000000-00000. Review.

PMID:
21668043
8.

Recombinant human growth hormone therapy in HIV-associated wasting and visceral adiposity.

Yin MT, Glesby MJ.

Expert Rev Anti Infect Ther. 2005 Oct;3(5):727-38. Review.

PMID:
16207164
9.

Effects of growth hormone-releasing hormone on visceral fat, metabolic, and cardiovascular indices in human studies.

Stanley TL, Grinspoon SK.

Growth Horm IGF Res. 2015 Apr;25(2):59-65. doi: 10.1016/j.ghir.2014.12.005. Epub 2014 Dec 20. Review.

10.

Management of fat accumulation in patients with HIV infection.

Falutz J.

Curr HIV/AIDS Rep. 2011 Sep;8(3):200-8. doi: 10.1007/s11904-011-0087-3. Review. Erratum in: Curr HIV/AIDS Rep. 2011 Dec;8(4):297-9.

PMID:
21739217
11.

Growth hormone in the aging male.

Sattler FR.

Best Pract Res Clin Endocrinol Metab. 2013 Aug;27(4):541-55. doi: 10.1016/j.beem.2013.05.003. Epub 2013 Jun 18. Review.

12.

Novel Approaches to Targeting Visceral and Hepatic Adiposities in HIV-Associated Lipodystrophy.

Tien PC.

Curr Atheroscler Rep. 2015 Dec;17(12):73. doi: 10.1007/s11883-015-0545-2. Review.

PMID:
26493063
13.

The Role of the Growth Hormone/Insulin-Like Growth Factor System in Visceral Adiposity.

Lewitt MS.

Biochem Insights. 2017 Apr 20;10:1178626417703995. doi: 10.1177/1178626417703995. eCollection 2017. Review.

14.

Interventions for body habitus changes associated with HIV infection and its treatment.

Tebas P.

Curr HIV/AIDS Rep. 2007 May;4(2):86-92. Review.

PMID:
17547830

Supplemental Content

Support Center